Member News

Opthea Launches A$45 Million Financing to Progress OPT- 302 Expanded Clinical Development

Opthea Limited (ASX:OPT) (“Opthea”), a developer of novel biologic therapies for the treatment of eye diseases, today announced the launch of an entitlement offer and institutional placement (collectively the “Offer”) to raise approximately A$45 million. Proceeds from the…

Bone, cartilage and tissue; we’ve cracked the trifecta (and it’s made of titanium and plastic)

We’ve been quietly working away in Melbourne on something big. The big trifecta of a bone, cartilage and tissue implant. The first of its kind. More specifically, a 3D printed titanium and polymer sternum to suit individual patients.  …

The US drug pricing debate: Managing risks to results

EY report on drug pricing The unsustainable trajectory of the health care spending in the US is generating much dialog and consternation across a variety of stakeholders including governments, industry, media academic think-tanks and the general public. Prescription…

New Director of Bio 21 announced

Professor Michael Parker has been appointed as the new Director of the University of Melbourne’s Bio 21 Molecular Science and Biotechnology Institute. One of Australia’s leading protein structural biologists, Prof Parker will take up the role as part…

Catalyst for efficient drug and chemical production

A team of CSIRO scientists have made a breakthrough that could result in faster and cheaper production for the pharmaceutical, food and bulk chemistry industries. The team have developed a more efficient and simpler process that – when…

Atomic map gives malaria drug new lease on life

Researchers have for the first time mapped how one of the longest-serving malaria drugs works, opening the possibility of altering its structure to make it more effective and combat increasing malaria drug resistance. The study produced a precise…

Fellowship Brings Leading Cancer Researcher To Victoria

One of the world’s best cancer researchers working to accelerate future treatments through DNA repair has received support from the Andrews Labor Government and veski to undertake research here in Victoria. Minister for Small Business, Innovation and Trade…

British Patient Recovering Successfully Following Implant of World-First 3D Printed Titanium and Polymer Sternum

Commonwealth Scientific and Industrial Research Organization (CSIRO), the federal government agency for scientific and medical research in Australia, successfully integrated 3D printed titanium and polymer sternum implants into a British patient. In partnership withAnatomics, a Melbourne-based medical device…

BioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee

The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for Melbourne’s membership,…

MyGolgi – Winners of the Innovation Showcase Scholarship

Melbourne-based health technology start-up company, MyGolgi, have won the 2016 Victorian State Government supported Innovation Showcase Scholarship. MyGolgi offer an easy-to-use wearable that provides consumers with continuous feedback for injury rehabilitation and prevention. The innovative device consists of…

Biomedical Breakthroughs takes close look at our bodies at Melbourne Museum

If you’re reading this through the misery of a mid-winter flu, at least you’re better off than the poor Bendigo boy who found himself in World War I with a bullet wound in the arm, tuberculosis in the…

Melbourne based Planet innovation tops the AFR 50 Most Innovative Companies 2016 list

Every year millions of people die or become gravely ill from infectious diseases such as influenza, HIV, Chlamydia and Zika virus. Currently, 80 per cent of all tests for infectious diseases involve taking a patient sample and sending…

Home

News & opinion

Member Directory

Events